Wang Xia
Impact in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Response and Inflammation
-
- Antimicrobial Peptides and Activities
Papers in
-
- COVID-19 epidemiological studies 3
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 2
- Co-authors
- Hui‐Hua Li (1 shared paper)Wei Cui (1 shared paper)Yong Xia (1 shared paper)Yulin Li (1 shared paper)Congcong Zhang (1 shared paper)Lei Wang (1 shared paper)Jie Du (1 shared paper)Jingjing Wang (6 shared papers)
- Journals
- International Immunopharmacology (2 papers)PLoS Computational Biology (2 papers)Toxicology and Applied Pharmacology (1 paper)China Finance Review International (1 paper)Aquaculture (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Wang Xia
21 papers receiving 350 citations
Peers
Comparison fields: 5 of 88
- Immunology 74
- Microbiology 17
- Infectious Diseases 49
- Cardiology and Cardiovascular Medicine 49
- Molecular Biology 126
Countries citing papers authored by Wang Xia
This map shows the geographic impact of Wang Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wang Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wang Xia more than expected).
Fields of papers citing papers by Wang Xia
This network shows the impact of papers produced by Wang Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wang Xia. The network helps show where Wang Xia may publish in the future.
Co-authors
The 25 scholars most cited alongside Wang Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 118 | |
| 2 | 2012 | 54 | |
| 3 | 2023 | 48 | |
| 4 | 2021 | 18 | |
| 5 | 2022 | 18 | |
| 6 | 2023 | 18 | |
| 7 | 2021 | 14 | |
| 8 | 2020 | 13 | |
| 9 | 2021 | 10 | |
| 10 | 2019 | 9 | |
| 11 | 2021 | 8 | |
| 12 | 2023 | 6 | |
| 13 | 2024 | 4 | |
| 14 | 2022 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2016 | 2 | |
| 17 | The Behavioral Explanation of Volatility Asymmetry in Chinese Stock Market | 2008 | 1 |
| 18 | Analysis on the utilization of antimicrobials and bacterial drug resistance in our hospital in 2010 | 2012 | 1 |
| 19 | 2010 | 1 | |
| 20 | 2024 | 1 |
About Wang Xia
Wang Xia is a scholar working on Modeling and Simulation, Immunology, Infectious Diseases, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 22 papers that have together received 352 indexed citations. Recurring topics across this work include COVID-19 epidemiological studies (3 papers), Epigenetics and DNA Methylation (3 papers), Viral Infections and Vectors (2 papers), Mosquito-borne diseases and control (2 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (2 papers), Influenza Virus Research Studies (2 papers), Nitric Oxide and Endothelin Effects (2 papers) and Tryptophan and brain disorders (1 paper). The work is most often cited by research in Immunology (74 citations), Microbiology (17 citations), Infectious Diseases (49 citations), Cardiology and Cardiovascular Medicine (49 citations) and Molecular Biology (126 citations). Wang Xia has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Hui‐Hua Li, Wei Cui, Yong Xia, Yulin Li, Congcong Zhang, Lei Wang, Jie Du, Jingjing Wang, Zhengtao Yang and Ershun Zhou. Their work appears in journals such as International Immunopharmacology, PLoS Computational Biology, Toxicology and Applied Pharmacology, China Finance Review International and Aquaculture.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.